HT-102

· Suzhou HepaThera Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HT-102, covering 2024-12-20 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection [Phase 2]